Invus Financial Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $6.01M | Hold |
350,884
| – | – | 6.74% | 6 |
|
|
2024
Q1 | $5.48M | Hold |
350,884
| – | – | 4.36% | 6 |
|
|
2023
Q4 | $5.24M | Hold |
350,884
| – | – | 4.1% | 7 |
|
|
2023
Q3 | $5.67M | Hold |
350,884
| – | – | 3.55% | 7 |
|
|
2023
Q2 | $14.6M | Hold |
350,884
| – | – | 7.79% | 5 |
|
|
2023
Q1 | $21.1M | Hold |
350,884
| – | – | 13.74% | 5 |
|
|
2022
Q4 | $25.7M | Hold |
350,884
| – | – | 13.69% | 4 |
|
|
2022
Q3 | $26.7M | Hold |
350,884
| – | – | 14.63% | 3 |
|
|
2022
Q2 | $24.4M | Hold |
350,884
| – | – | 14.72% | 3 |
|
|
2022
Q1 | $29.1M | Hold |
350,884
| – | – | 12.93% | 5 |
|
|
2021
Q4 | $26.3M | Hold |
350,884
| – | – | 8.01% | 5 |
|
|
2021
Q3 | $40.8M | Hold |
350,884
| – | – | 10.92% | 4 |
|
|
2021
Q2 | $77.8M | Hold |
350,884
| – | – | 15.51% | 3 |
|
|
2021
Q1 | $46.4M | Hold |
350,884
| – | – | 10.63% | 4 |
|
|
2020
Q4 | $60.7M | Hold |
350,884
| – | – | 25.38% | 1 |
|
|
2020
Q3 | $39.1M | Sell |
350,884
-120,000
| -25% | -$13.4M | 18.79% | 3 |
|
|
2020
Q2 | $27.9M | Hold |
470,884
| – | – | 10.09% | 5 |
|
|
2020
Q1 | $31.7M | Hold |
470,884
| – | – | 15.57% | 3 |
|
|
2019
Q4 | $39.7M | Buy |
+470,884
| New | +$39.7M | 20.13% | 3 |
|